NevadaSB35483rd Regular Session (2025)SenateWALLET

AN ACT relating to insurance; prohibiting certain health plans from requiring step therapy before providing coverage for certain prescription drugs for the prevention of human immunodeficiency virus or the treatment of human immunodeficiency virus or hepatitis C; and providing other matters properly relating thereto.

Sponsored By: Jeff Stone (Republican)

Failed

BDR 57-1041

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

2 provisions identified: 1 benefits, 1 costs, 0 mixed.

Fewer HIV and hepatitis C insurance barriers

For policies issued, delivered, or renewed starting January 1, 2027, most Nevada health plans cannot use these treatment barriers. These include prior approval requirements and making patients try another drug first. The protection covers FDA-approved drugs to prevent HIV or treat HIV or hepatitis C, plus lab tests needed for HIV-prevention drugs. It also covers primary-care services within the provider’s scope, or safely provided with specialist consultation. Covered services from network pharmacists also receive this protection. Separate rules apply to the public employee and Medicaid plans described below.

Some public plans keep drug trial rules

Beginning January 1, 2027, managed care plans serving Nevada Medicaid or Public Employees’ Benefits Program members can retain step therapy. This means a plan can require patients to try another drug first. The public employee program’s Board can also use this rule when it provides a self-insured plan. This permission covers required HIV-prevention and HIV or hepatitis C treatment benefits, including related tests and listed provider services. These plans are allowed, but not required, to use step therapy.

Sponsors & Cosponsors

Sponsor

  • Jeff Stone

    Republican • Senate

Cosponsors

  • Rebecca Edgeworth

    Republican • House

  • James Ohrenschall

    Democratic • Senate

  • Melanie Scheible

    Democratic • Senate

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. (No further action taken.)

    6/3/2025Senate
  2. From printer. To engrossment. Engrossed. First reprint. To committee.

    4/25/2025Senate
  3. Taken from General File. Re-referred to Committee on Finance. Exemption effective. To printer.

    4/22/2025Senate
  4. Notice of eligibility for exemption.

    4/22/2025Senate
  5. Reprinting dispensed with.

    4/21/2025Senate
  6. Read second time. Amended. (Amend. No. 315.)

    4/21/2025Senate
  7. Placed on Second Reading File.

    4/21/2025Senate
  8. From committee: Amend, and do pass as amended.

    4/21/2025Senate
  9. From printer. To committee.

    3/17/2025Senate
  10. Read first time. Referred to Committee on Commerce and Labor. To printer.

    3/13/2025Senate

Bill Text

Related Bills

Back to State Legislation